In this article, Insider Financial takes a look at penny stocks on the move: MCOA, CBDD, BTDG, RSCF. We are doing this to update our regular readers on what is happening in the land of penny stocks. We are not focused on the bagholders, but rather the penny stocks that are moving and why.
As we have stressed repeatedly to our subscribers, the key to trading penny stocks is finding momentum BEFORE it happens. We got our subscribers in early on TSNP, which you can read our latest here, ENZC, which you can read about here, and recently CBDD, which you can read here.
Now, when we say that we find momentum BEFORE it happens, we are swing traders looking to position our subscribers BEFORE the move happens. This is where the big money is made and why so many of our subscribers are sitting on gains of over 5000% in ENZC and over 10,000% in TSNP. If you want to day trade, this is not the place for you. If you want to make a few hundred bucks and then lose a thousand the next, we hear Tim Sykes has plenty of openings.
Now that we got that out the way, here are 4 penny stocks on the move.
MCOA jumped 160% yesterday on its first big green day on massive volume. We love days like this because it’s a potential sign of the start of a multi-day run. As you can see from the chart below, it’s been a painful year for MCOA shareholders.
MCOA is moving like other mj plays on the enthusiasm of Joe Biden going into the White House. MCOA is a hemp and cannabis corporation selling under the hempSMART™ name. MCOA trades on the Pink Sheets on the OTC Markets and has a current market cap of $11 million.
The reason for the share price weakness has been toxic convertible debt. Anyone trading pennies knows that this is bad news. However, the company is working to turn things around. MCOA has pivoted from big debt financing and towards equity financing, which can be seen by the recent S1 Registration statement.
While it’s too early to say if the company will be successful or not, we can see MCOA running as penny stock traders looking for cheap mj plays to bid up.
CBDD is a play that we got our subscribers in early. Our article was published November 17th, but subscribers got an early look a few days before.
CBDD is an undervalued play on the OTC Markets that just reported gross revenues increased nearly 10-fold over the second quarter to $5,963,820.00 with gross profits of $484,666.00.
CBDD offers a superior CBD product that is full-spectrum without depending on THC to activate the benefits of cannabidiol. Black Pearl CBD has 0% THC but is not an Isolate where the THC is stripped from the product rendering it ineffective. CBBD uses a proprietary technique adding terpenes as the activation ingredient, resulting in a product that is the finest in the industry.
CBDD just announced a Swiss pilot program to permit temporary production and distribution of marijuana.
“If the pilot program is successful, CBD of Denver, Inc, Rockflowr Exchange, Rockflowr Production and Rockflowr Retail could dramatically benefit by using their expertise in CBD and hemp industry to move into the very lucrative marijuana business” explained Marcel Gamma.
BTDG has a history of big price spikes and we saw some major moves over the summer. Now BTDG has formed a rounding bottom and has started rebounding.
BTDG is now forging ahead and becoming a full-service live event sports company. Capitalizing on the combination of B2Digital CEO Greg P. Bell’s expertise and involvement with more than 40,000 live events over his career for major sports leagues and entertainment venues, B2Digital is in the process of developing and acquiring MMA and sports-related companies to build an integrated Premier Development League, Expand the B2 Official Training Facility Program Network and Continue the growth of the B2 Social Media Network for the MMA industry.
BTDG has a current market cap of just $6.6 million. What we like about BTDG is that there are 707 million shares outstanding, but 425 million shares are restricted. BTDG can get moving if some big volume starts coming into the stock.
RSCF jumped 311% yesterday after the company announced a patent has been granted by the United States Patent Office for an ultracold shipping and storage container for transportation by air that uses liquid nitrogen technology for cooling.
The large state-of-the-art shipping system could carry many thousands of doses of vaccines and utilizes the commercially proven Cryometrix patented cooling and freezing technology that has the flexibility to provide precise temperature control across a wide range of temperatures.
The system accommodates payloads ranging from those requiring conventional refrigeration to specialty products such as COVID-19 and related vaccines that may require temperatures as low as -80° centigrade (-112° Fahrenheit). Systems can be configured to provide for short or long duration shipping cycles, making it an ideal choice for the cold chain management.
This is significant because Pfizer’s vaccine requires it to be stored in cold temperatures.
RSCF is a penny stock runner that we would wait to buy on dips.
There’s no shortage of penny stock runners on the OTC Markets right now. MCOA CBDD BTDG RSCF all made big moves. Of the four, we like CBDD the best. It’s why we alerted our subscribers early. The company is reporting explosive revenue growth and is undervalued. We believe cannabis plays will continue to run into 2021 as Joe Biden enters the White House. Now is a great time to be a penny stock trader.
As always, good luck to all (except the shorts)!
WHEN INSIDER FINANCIAL HAS A STOCK ALERT, IT CAN PAY TO LISTEN. AFTER ALL, OUR FREE NEWSLETTER HAS FOUND MANY TRIPLE-DIGIT WINNERS FOR OUR SUBSCRIBERS. WE SPECIALIZE IN FINDING MOMENTUM BEFORE IT HAPPENS!
Disclosure: We have no position in any of the securities mentioned. We wrote this article ourselves and it expresses our own opinions. We are not receiving compensation for it. We have no business relationship with any company whose stock is mentioned in this article. Insider Financial is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This article is not a solicitation or recommendation to buy, sell, or hold securities. This article is meant for informational and educational purposes only and does not provide investment advice.